Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 120

1.

Pro-inflammatory CX3CR1+ CD59+ TL1A+ IL-23+ monocytes are expanded in patients with Ankylosing Spondylitis and modulate ILC3 immune functions.

Ciccia F, Guggino G, Zeng M, Thomas R, Ranganathan V, Rahman A, Alessandro R, Rizzo A, Saieva L, Macaluso F, Peralta S, Di Liberto D, Dieli F, Cipriani P, Giacomelli R, Baeten D, Haroon N.

Arthritis Rheumatol. 2018 Jun 5. doi: 10.1002/art.40582. [Epub ahead of print]

PMID:
29869839
2.

European week of sport: innovative initiative of European Commission that inspires children to be active.

Barone R, Marino Gammazza A, Casarrubea M, De Martino L, Marino Gammazza M, Monachino F, Barone P, Termini F, Sammartino B, Campanella C, Di Felice V, Cappello F, Macaluso F.

J Sports Med Phys Fitness. 2018 May 29. doi: 10.23736/S0022-4707.18.08458-X. [Epub ahead of print]

PMID:
29845837
3.

Quadricuspid Pulmonic Valve, Pulmonary Artery Aneurysm, and Apical Hypertrophic Cardiomyopathy: A Rare Combination.

Guijarro-Contreras A, Pardo-Martínez P, Cham M, Macaluso F, Sanz-Salvo J.

Circ Cardiovasc Imaging. 2018 Jun;11(6):e007698. doi: 10.1161/CIRCIMAGING.118.007698. No abstract available.

PMID:
29807888
4.

How clinicians and pathologists interact concerning inflammatory bowel disease in Italy: An IG-IBD survey.

Macaluso FS, Orlando A, Bassotti G, Rizzo AG, Armuzzi A, Villanacci V; Collaborating Authors, Antonelli E, Ventimiglia M, Cottone M, Rizzello F.

Dig Liver Dis. 2018 Mar 21. pii: S1590-8658(18)30257-3. doi: 10.1016/j.dld.2018.03.020. [Epub ahead of print] No abstract available.

PMID:
29680467
5.

Pathogenesis of polymyalgia rheumatica.

Guggino G, Ferrante A, Macaluso F, Triolo G, Ciccia F.

Reumatismo. 2018 Mar 27;70(1):10-17. doi: 10.4081/reumatismo.2018.1048.

6.

Citron kinase-dependent F-actin maintenance at midbody secondary ingression sites mediates abscission.

Dema A, Macaluso F, Sgrò F, Berto GE, Bianchi FT, Chiotto AA, Pallavicini G, Di Cunto F, Gai M.

J Cell Sci. 2018 Apr 26;131(8). pii: jcs209080. doi: 10.1242/jcs.209080.

PMID:
29588396
7.

The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases.

Macaluso FS, Orlando R, Fries W, Scolaro M, Magnano A, Pluchino D, Cappello M, Morreale GC, Siringo S, Privitera AC, Ferracane C, Belluardo N, Alberghina N, Ventimiglia M, Rizzuto G, Renna S, Cottone M, Orlando A.

Dig Liver Dis. 2018 Mar 1. pii: S1590-8658(18)30211-1. doi: 10.1016/j.dld.2018.02.013. [Epub ahead of print]

PMID:
29576495
8.

Letter: the addition of an immunosuppressant in patients with unsatisfactory response to vedolizumab.

Macaluso FS, Orlando R, Renna S, Sapienza C, Ventimiglia M, Rizzuto G, Cottone M, Orlando A.

Aliment Pharmacol Ther. 2018 Apr;47(7):1040-1041. doi: 10.1111/apt.14541. No abstract available.

PMID:
29512915
9.

The Addition of an Immunosuppressant After Loss of Response to Anti-TNFα Monotherapy in Inflammatory Bowel Disease: A 2-Year Study.

Macaluso FS, Sapienza C, Ventimiglia M, Renna S, Rizzuto G, Orlando R, Di Pisa M, Affronti M, Orlando E, Cottone M, Orlando A.

Inflamm Bowel Dis. 2018 Jan 18;24(2):394-401. doi: 10.1093/ibd/izx010.

PMID:
29361087
10.

Is Epstein-Barr virus infection associated with the pathogenesis of microscopic colitis?

Rizzo AG, Orlando A, Gallo E, Bisanti A, Sferrazza S, Montalbano LM, Macaluso FS, Cottone M.

J Clin Virol. 2017 Dec;97:1-3. doi: 10.1016/j.jcv.2017.10.009. Epub 2017 Oct 20.

PMID:
29078077
11.

Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

Ruscitti P, Margiotta DPE, Macaluso F, Iacono D, D'Onofrio F, Emmi G, Atzeni F, Prete M, Perosa F, Sarzi-Puttini P, Emmi L, Cantatore FP, Triolo G, Afeltra A, Giacomelli R, Valentini G.

Medicine (Baltimore). 2017 Oct;96(42):e8180. doi: 10.1097/MD.0000000000008180.

12.

Screening of colorectal cancer: present and future.

Maida M, Macaluso FS, Ianiro G, Mangiola F, Sinagra E, Hold G, Maida C, Cammarota G, Gasbarrini A, Scarpulla G.

Expert Rev Anticancer Ther. 2017 Dec;17(12):1131-1146. doi: 10.1080/14737140.2017.1392243. Epub 2017 Oct 26. Review.

PMID:
29022408
13.

Increased localization of APP-C99 in mitochondria-associated ER membranes causes mitochondrial dysfunction in Alzheimer disease.

Pera M, Larrea D, Guardia-Laguarta C, Montesinos J, Velasco KR, Agrawal RR, Xu Y, Chan RB, Di Paolo G, Mehler MF, Perumal GS, Macaluso FP, Freyberg ZZ, Acin-Perez R, Enriquez JA, Schon EA, Area-Gomez E.

EMBO J. 2017 Nov 15;36(22):3356-3371. doi: 10.15252/embj.201796797. Epub 2017 Oct 10.

14.

Risk of Pneumonia Caused by Pneumocystis jiroveci in Inflammatory Bowel Disease: The Role of Concomitant Pulmonary Comorbidities.

Macaluso FS, Cottone M, Orlando A.

Clin Gastroenterol Hepatol. 2017 Jun 15. pii: S1542-3565(17)30726-7. doi: 10.1016/j.cgh.2017.06.020. [Epub ahead of print] No abstract available.

PMID:
28625815
15.

Tolerability profile of thiopurines in inflammatory bowel disease: a prospective experience.

Macaluso FS, Renna S, Maida M, Dimarco M, Sapienza C, Affronti M, Orlando E, Rizzuto G, Orlando R, Ventimiglia M, Cottone M, Orlando A.

Scand J Gastroenterol. 2017 Sep;52(9):981-987. doi: 10.1080/00365521.2017.1333626. Epub 2017 May 29.

PMID:
28554266
16.

Diagnostic and vaccine strategies to prevent infections in patients with inflammatory bowel disease.

Mazzola G, Macaluso FS, Adamoli L, Renna S, Cascio A, Orlando A.

J Infect. 2017 May;74(5):433-441. doi: 10.1016/j.jinf.2017.02.009. Epub 2017 Mar 2. Review.

PMID:
28263759
17.

Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease.

Orlando A, Orlando R, Ciccia F, Renna S, Rizzo A, Cottone M, Macaluso FS.

Ann Rheum Dis. 2017 Sep;76(9):e31. doi: 10.1136/annrheumdis-2016-211011. Epub 2017 Jan 17. No abstract available.

PMID:
28096071
18.

Clinical Course and Genetic Susceptibility of Primary Biliary Cirrhosis: Analysis of a Prospective Cohort.

Almasio PL, Licata A, Maida M, Macaluso FS, Costantino A, Alessi N, Grimaudo S, Accardi G, Caruso C, Craxi A.

Hepat Mon. 2016 Oct 16;16(11):e31681. doi: 10.5812/hepatmon.31681. eCollection 2016 Nov.

19.

The biologics of ulcerative colitis.

Macaluso FS, Renna S, Orlando A, Cottone M.

Expert Opin Biol Ther. 2017 Feb;17(2):175-184. doi: 10.1080/14712598.2017.1271871. Epub 2016 Dec 21. Review.

PMID:
27960557
20.

Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressants.

Macaluso FS, Maida M, Renna S, Orlando E, Affronti M, Sapienza C, Dimarco M, Orlando R, Rizzuto G, Cottone M, Orlando A.

Dig Liver Dis. 2017 Feb;49(2):157-162. doi: 10.1016/j.dld.2016.10.001. Epub 2016 Oct 14.

PMID:
27876682
21.

Non-Invasive Assessment of Liver Injury in Non-Alcoholic Fatty Liver Disease: A Review of Literature.

Maida M, Macaluso FS, Salomone F, Petta S.

Curr Mol Med. 2016;16(8):721-737. Review.

PMID:
27719652
22.

Frequency of thiopurine methyltransferase mutation in patients of Mediterranean area with inflammatory bowel disease and autoimmune disorders.

Di Salvo A, Fabiano C, Mannara V, Dimarco M, Orlando A, Affronti M, Macaluso FS, Cottone M.

Dig Liver Dis. 2016 Dec;48(12):1506-1509. doi: 10.1016/j.dld.2016.08.125. Epub 2016 Sep 1.

PMID:
27665263
23.

CLEM Methods for Studying Primary Cilia.

Macaluso FP, Perumal GS, Kolstrup J, Satir P.

Methods Mol Biol. 2016;1454:193-202. doi: 10.1007/978-1-4939-3789-9_12.

PMID:
27514923
24.

Effects of Conjugated Linoleic Acid Associated With Endurance Exercise on Muscle Fibres and Peroxisome Proliferator-Activated Receptor γ Coactivator 1 α Isoforms.

Barone R, Sangiorgi C, Marino Gammazza A, D'Amico D, Salerno M, Cappello F, Pomara C, Zummo G, Farina F, Di Felice V, Macaluso F.

J Cell Physiol. 2017 May;232(5):1086-1094. doi: 10.1002/jcp.25511. Epub 2016 Sep 21.

PMID:
27487028
25.

Letter: a prospective real life comparison of the efficacy of adalimumab vs. golimumab in moderate to severe ulcerative colitis.

Renna S, Orlando E, Macaluso FS, Maida M, Affronti M, Giunta M, Sapienza C, Rizzuto G, Orlando R, Dimarco M, Cottone M, Orlando A.

Aliment Pharmacol Ther. 2016 Aug;44(3):310-1. doi: 10.1111/apt.13692. No abstract available.

26.

Complete and Sustained Off-Therapy Response to Sorafenib in Advanced Hepatocellular Carcinoma.

Maida M, Macaluso FS, Valenza F, Virdone R.

J Gastrointestin Liver Dis. 2016 Jun;25(2):253-5. doi: 10.15403/jgld.2014.1121.252.off.

27.

Aerobic Exercise and Pharmacological Treatments Counteract Cachexia by Modulating Autophagy in Colon Cancer.

Pigna E, Berardi E, Aulino P, Rizzuto E, Zampieri S, Carraro U, Kern H, Merigliano S, Gruppo M, Mericskay M, Li Z, Rocchi M, Barone R, Macaluso F, Di Felice V, Adamo S, Coletti D, Moresi V.

Sci Rep. 2016 May 31;6:26991. doi: 10.1038/srep26991.

28.

The METEOR Trial: The Burial of Methotrexate in Ulcerative Colitis?

Macaluso FS, Renna S, Cottone M, Orlando A.

Gastroenterology. 2016 Jul;151(1):211-2. doi: 10.1053/j.gastro.2016.02.085. Epub 2016 May 28. No abstract available.

PMID:
27243641
29.

The Selective Use of Combination Therapy in Patients with Inflammatory Bowel Disease Resistant to Anti-TNF: to Whom, How and How Long?

Macaluso FS, Cottone M, Orlando A.

J Crohns Colitis. 2016 Dec;10(12):1451. Epub 2016 Apr 28. No abstract available.

PMID:
27125641
30.

Letter: switching from one to another anti-tumour necrosis factor alpha agent, and the risks of an overlap of exposure.

Macaluso FS, Criscuoli V, Orlando E, Rizzuto G, Renna S, Cottone M, Orlando A.

Aliment Pharmacol Ther. 2016 May;43(9):1019-20. doi: 10.1111/apt.13565. No abstract available.

31.

Skeletal muscle Heat shock protein 60 increases after endurance training and induces peroxisome proliferator-activated receptor gamma coactivator 1 α1 expression.

Barone R, Macaluso F, Sangiorgi C, Campanella C, Marino Gammazza A, Moresi V, Coletti D, Conway de Macario E, Macario AJ, Cappello F, Adamo S, Farina F, Zummo G, Di Felice V.

Sci Rep. 2016 Jan 27;6:19781. doi: 10.1038/srep19781.

32.

Alcoholic Liver Disease: A Mouse Model Reveals Protection by Lactobacillus fermentum.

Barone R, Rappa F, Macaluso F, Caruso Bavisotto C, Sangiorgi C, Di Paola G, Tomasello G, Di Felice V, Marcianò V, Farina F, Zummo G, Conway de Macario E, Macario AJ, Cocchi M, Cappello F, Marino Gammazza A.

Clin Transl Gastroenterol. 2016 Jan 21;7:e138. doi: 10.1038/ctg.2015.66.

33.

Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Macaluso FS, Maida M, Petta S.

World J Gastroenterol. 2015 Oct 21;21(39):11088-111. doi: 10.3748/wjg.v21.i39.11088. Review.

34.

SFRR-E Young Investigator AwardeeαB-crystallin modulation after acute exercise in skeletal muscle: the role of oxidative stress and fiber composition.

Grazioli E, Dimauro I, Mercatelli N, Barone R, Macaluso F, Fittipaldi S, Di Felice V, Caporossi D.

Free Radic Biol Med. 2014 Oct;75 Suppl 1:S13-4. doi: 10.1016/j.freeradbiomed.2014.10.585. Epub 2014 Dec 10.

PMID:
26461288
35.

Hepatitis C Virus Infection Is Associated With Increased Cardiovascular Mortality: A Meta-Analysis of Observational Studies.

Petta S, Maida M, Macaluso FS, Barbara M, Licata A, Craxì A, Cammà C.

Gastroenterology. 2016 Jan;150(1):145-155.e4; quiz e15-6. doi: 10.1053/j.gastro.2015.09.007. Epub 2015 Sep 18. Review.

PMID:
26386298
36.

TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C.

Petta S, Maida M, Grimaudo S, Pipitone RM, Macaluso FS, Cabibi D, Cammà C, Di Marco V, Sferrazza S, Craxì A.

Liver Int. 2016 Feb;36(2):198-204. doi: 10.1111/liv.12918. Epub 2015 Aug 8.

PMID:
26259026
37.

Residual risk of hepatocellular carcinoma after HCV eradication: more than meets the eye.

Macaluso FS, Calvaruso V, Craxì A.

Future Microbiol. 2015;10(6):977-88. doi: 10.2217/fmb.15.31. Review.

PMID:
26059621
38.

The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease.

Petta S, Maida M, Macaluso FS, Di Marco V, Cammà C, Cabibi D, Craxì A.

Hepatology. 2015 Oct;62(4):1101-10. doi: 10.1002/hep.27844. Epub 2015 May 20.

PMID:
25991038
39.

PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.

Petta S, Vanni E, Bugianesi E, Rosso C, Cabibi D, Cammà C, Di Marco V, Eslam M, Grimaudo S, Macaluso FS, McLeod D, Pipitone RM, Abate ML, Smedile A, George J, Craxì A.

Aliment Pharmacol Ther. 2015 May;41(10):939-48. doi: 10.1111/apt.13169. Epub 2015 Mar 20.

40.

Cecal volvulus in giant ventral hernia.

Reznichenko AA, Macaluso F, Zulim R.

Int J Surg Case Rep. 2015;10:25-9. doi: 10.1016/j.ijscr.2015.03.019. Epub 2015 Mar 12.

41.

The hepatic expression of vitamin D receptor is inversely associated with the severity of liver damage in genotype 1 chronic hepatitis C patients.

Petta S, Grimaudo S, Tripodo C, Cabibi D, Calvaruso M, Di Cristina A, Guarnotta C, Macaluso FS, Minissale MG, Marchesini G, Craxì A.

J Clin Endocrinol Metab. 2015 Jan;100(1):193-200. doi: 10.1210/jc.2014-2741.

PMID:
25268393
42.

Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study.

Licata A, Maida M, Cabibi D, Butera G, Macaluso FS, Alessi N, Caruso C, Craxì A, Almasio PL.

Dig Liver Dis. 2014 Dec;46(12):1116-20. doi: 10.1016/j.dld.2014.08.040. Epub 2014 Sep 16.

PMID:
25224696
43.

Value of CMR for the differential diagnosis of cardiac masses.

Pazos-López P, Pozo E, Siqueira ME, García-Lunar I, Cham M, Jacobi A, Macaluso F, Fuster V, Narula J, Sanz J.

JACC Cardiovasc Imaging. 2014 Sep;7(9):896-905. doi: 10.1016/j.jcmg.2014.05.009. Epub 2014 Aug 13.

44.

Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

Petta S, Cabibbo G, Enea M, Macaluso FS, Plaia A, Bruno R, Gasbarrini A, Bruno S, Craxì A, Cammà C; WEF study group.

Dig Liver Dis. 2014 Oct;46(10):936-42. doi: 10.1016/j.dld.2014.06.009. Epub 2014 Jul 23.

PMID:
25066806
45.

Molecular analysis of chromium and cobalt-related toxicity.

Scharf B, Clement CC, Zolla V, Perino G, Yan B, Elci SG, Purdue E, Goldring S, Macaluso F, Cobelli N, Vachet RW, Santambrogio L.

Sci Rep. 2014 Jul 17;4:5729. doi: 10.1038/srep05729.

46.

Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.

Macaluso FS, Maida M, Cammà C, Cabibbo G, Cabibi D, Alduino R, Di Marco V, Craxì A, Petta S.

J Hepatol. 2014 Sep;61(3):523-9. doi: 10.1016/j.jhep.2014.04.045. Epub 2014 May 9.

PMID:
24815874
47.

Imaging the alphavirus exit pathway.

Martinez MG, Snapp EL, Perumal GS, Macaluso FP, Kielian M.

J Virol. 2014 Jun;88(12):6922-33. doi: 10.1128/JVI.00592-14. Epub 2014 Apr 2.

48.

Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

Petta S, Cabibbo G, Enea M, Macaluso FS, Plaia A, Bruno R, Gasbarrini A, Craxì A, Cammà C; WEF Study Group.

Hepatology. 2014 May;59(5):1692-705. doi: 10.1002/hep.27010. Epub 2014 Apr 1.

PMID:
24691835
49.

Maximum water temperature limit in open-water swimming events.

Macaluso F, Barone R, Isaacs AW, Farina F, Morici G, Di Felice V.

Wilderness Environ Med. 2014 Jun;25(2):245-6. doi: 10.1016/j.wem.2013.12.002. Epub 2014 Mar 13. No abstract available.

PMID:
24631227
50.

Acute change of titin at mid-sarcomere remains despite 8 wk of plyometric training.

Macaluso F, Isaacs AW, Di Felice V, Myburgh KH.

J Appl Physiol (1985). 2014 Jun 1;116(11):1512-9. doi: 10.1152/japplphysiol.00420.2013. Epub 2014 Jan 23.

Supplemental Content

Loading ...
Support Center